Observational studyJournal of cachexia, sarcopenia and muscle2024

Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study.

Ilaria Trestini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.